Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia

Newer approaches are needed for the treatment of relapsed and refractory acute lymphoblastic leukemia (ALL). Asparaginase-based regimens are active in the treatment of pediatric ALL and may be important in salvage therapy for adult patients. We conducted a pilot trial combining methotrexate, vincris...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Hematol
Autores principales: Kadia, Tapan M., Kantarjian, Hagop M., Thomas, Deborah A., O’Brien, Susan, Estrov, Zeev, Ravandi, Farhad, Jabbour, Elias, Pemmaraju, Naveen, Daver, Naval, Wang, Xuemei, Jain, Preetesh, Pierce, Sherry, Brandt, Mark, Garcia-Manero, Guillermo, Cortes, Jorge, Borthakur, Gautam
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447180/
https://ncbi.nlm.nih.gov/pubmed/25368968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23886
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares